Octapharma AB (manufacturer responsible for production on a full cycle, except secondary packaging)
UkraineAll drugs from this manufacturer
-
It is used for the prevention of Rh immunization in women of childbearing age with a negative Rh factor. This includes both planned prophylaxis during pregnancy and protection after childbirth (if the baby is Rh-positive), as well as after certain pregnancy complications or medical procedures.
Dosage form: solution for injection
Active substance Dosage human anti-d immunoglobulin 625 IU/ml or 1250 IU/2 ml ATC: J06BB01
-
It is used for the prevention of Rh immunization in women of reproductive age with a negative Rh factor. This includes both prophylaxis during pregnancy (antenatal) and after the birth of an Rh-positive child (postnatal). The drug is also used to treat women who have received incompatible Rh-positive blood.
Dosage form: solution for injection
Active substance Dosage human anti-d immunoglobulin 750 IU/ml ATC: J06BB01